Gilead Updates 2020 Guidance with Post-Holiday COVID-19 Spike

Gilead Updates 2020 Guidance with Post-Holiday COVID-19 Spike

Source: 
BioSpace
snippet: 

Gilead Sciences’ Veklury, which is better known by its scientific name remdesivir, is the only antiviral drug currently approved to treat COVID-19. Despite some controversy over its effectiveness, it is bolstering the company’s bottom line and Gilead recently updated its 2020 guidance to reflect that.